InsidersTradesSigma
Browse the full record of transactions filed by Layman Melissa, Directeur Commercial. Insider active across 1 companies, notably Flexion Therapeutics Inc. Aggregated, 2 filings have been recorded. The latest transaction was disclosed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Melissa Layman is Chief Commercial Officer at Flexion Therapeutics Inc. She oversees the company's commercial and marketing initiatives. Her expertise in the pharmaceutical sector is essential in supporting the growth and innovation of the organization.